Congratulations to GCA Founding Board member Verdure Sciences for winning the Nutraingredients-USA Nutrition Research Project Award for their Retinal Amyloid Pathology and Proof-of-Concept Imaging Clinical Trial with Longvida Optimized Curcumin. This category rewards the most innovative and […]
Researchers in this recent trial on curcumin concluded “Curcumin is a safe and tolerable adjunct to FOLFOX chemotherapy in patients with metastatic colorectal cancer.” Link to Story
Recently there have been some global headlines surrounding turmeric and choleastatic hepatitis. The Global Curcumin Association recognizes the seriousness of the condition with which these nine people are contending, and we send best wishes for their speedy recovery. We also think it is important […]
Natural Products Insider has published an overview of recent curcumin and turmeric research
Link to Story
New survey from CRN finds that 20% of supplement users age 55 and older take turmeric and curcumin supplements. Read More
A recent study published in the Journal of Evidence-based Integrative Medicine describes research that examined the Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut Microbiota observing that treated subjects could be divided into two groups […]
Research in mice suggests that curcumin treatment significantly reduces tumor burden in immunocompromised mice and synergizes with the therapeutic proteasome inhibitor carfilzomib to induce apoptosis in a variety of proteasome-addicted cancer cells.
Link to Story […]
Noblesville, IN-based Verdure Sciences has joined The Global Curcumin Association (GCA) as a Founding Board member alongside Sabinsa Corporation. Verdure is the developer of Longvida Optimized Curcumin.
Link to Story
According to research published in the journal Inflammopharmacology, researchers investigated the effect of polar extract of turmeric (C. longa (NR-INF-02)) on cartilage homeostasis in human articular chondrocytes knee (NHAC-kn) cells to understand its mechanism of action.
Link to Story […]